My role at SAS puts me in an interesting position. Because I oversee 3 distinct (though converging) markets – healthcare, health plans, and life sciences – I often find myself needing to switch mental gears many times during the day. A 9:00 meeting might be related to drug development, my 10:00 about fraudulent health claims, and my 11:00 about selling to physicians (and yes, I have a lot of meetings). Besides making for interesting days, I’m fortunate to be able to see areas of overlap and commonality. Such is the case with protocols.
Continue reading “You Say Tomato, I Say Protocol”
